Histone deacetylases (HDACs) are critical epigenetic regulators that remove acetyl groups from lysine residues on histone and non-histone proteins, thereby modulating chromatin structure and gene expression. HDAC assay kits have become indispensable for quantifying HDAC activity, screening inhibitors, and advancing research in cancer, neurodegeneration, and other diseases. 

Applications

• Epigenetic Research: Quantification of HDAC activity in cell and tissue extracts to study chromatin dynamics and gene regulation.
• Drug Discovery: High-throughput screening for small molecule HDAC inhibitors, relevant for cancer and neurodegenerative disease therapeutics.
• Disease Mechanisms: Investigating HDAC dysregulation in diseases such as cancer, COPD, and Huntington’s disease.
• Proteomics: Profiling HDAC activity across different biological samples and conditions.

Advantages

• High Sensitivity: Detects HDAC activity from at low concentration.
• Non-Radioactive: Utilizes colorimetric or fluorometric detection, avoiding hazardous radioisotopes.
• High Throughput: 96-well format enables large-scale screening.
• Versatility: Compatible with purified enzymes, nuclear extracts, and cell/tissue lysates.

HDAC assay kits are essential tools for studying histone deacetylation, screening epigenetic modulators, and elucidating disease mechanisms. Their sensitivity, adaptability, and ease of use make them indispensable in both basic and translational research.